A Functional Genomics Approach to Henipavirus Research: The Role of Nuclear Proteins, MicroRNAs and Immune Regulators in Infection and Disease

  • Cameron R. StewartEmail author
  • Celine Deffrasnes
  • Chwan Hong Foo
  • Andrew G. D. Bean
  • Lin-Fa Wang
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 419)


Hendra and Nipah viruses (family Paramyxoviridae, genus Henipavirus) are zoonotic RNA viruses that cause lethal disease in humans and are designated as Biosafety Level 4 (BSL4) agents. Moreover, henipaviruses belong to the same group of viruses that cause disease more commonly in humans such as measles, mumps and respiratory syncytial virus. Due to the relatively recent emergence of the henipaviruses and the practical constraints of performing functional genomics studies at high levels of containment, our understanding of the henipavirus infection cycle is incomplete. In this chapter we describe recent loss-of-function (i.e. RNAi) functional genomics screens that shed light on the henipavirus–host interface at a genome-wide level. Further to this, we cross-reference RNAi results with studies probing host proteins targeted by henipavirus proteins, such as nuclear proteins and immune modulators. These functional genomics studies join a growing body of evidence demonstrating that nuclear and nucleolar host proteins play a crucial role in henipavirus infection. Furthermore these studies will underpin future efforts to define the role of nucleolar host–virus interactions in infection and disease.


  1. Alexiou P et al (2010) The DIANA-mirExTra web server: from gene expression data to microRNA function. PLoS One 5(2):e9171PubMedPubMedCentralGoogle Scholar
  2. Alexopoulou L et al (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413(6857):732–738PubMedGoogle Scholar
  3. Andrejeva J et al (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 101(49):17264–17269PubMedPubMedCentralGoogle Scholar
  4. Ang F et al (2010) Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus. Virol J 7:24PubMedPubMedCentralGoogle Scholar
  5. Au HH, Jan E (2014) Novel viral translation strategies. Wiley Interdiscip Rev RNA 5(6):779–801PubMedGoogle Scholar
  6. Audsley MD, Moseley GW (2013) Paramyxovirus evasion of innate immunity: diverse strategies for common targets. World J Virol 2(2):57–70PubMedPubMedCentralGoogle Scholar
  7. Baek D et al (2008) The impact of microRNAs on protein output. Nature 455(7209):64–71PubMedPubMedCentralGoogle Scholar
  8. Bharaj P et al (2016) The Matrix Protein of Nipah Virus Targets the E3-Ubiquitin Ligase TRIM6 to Inhibit the IKKepsilon Kinase-Mediated Type-I IFN Antiviral Response. PLoS Pathog 12(9):e1005880PubMedPubMedCentralGoogle Scholar
  9. Birmingham A et al (2009) Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods 6(8):569–575PubMedPubMedCentralGoogle Scholar
  10. Bonaparte MI et al (2005) Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A 102(30):10652–10657PubMedPubMedCentralGoogle Scholar
  11. Brass AL et al (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319(5865):921–926PubMedGoogle Scholar
  12. Brass AL et al (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139(7):1243–1254PubMedPubMedCentralGoogle Scholar
  13. Carette JE et al (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477(7364):340–343PubMedPubMedCentralGoogle Scholar
  14. Childs K et al (2007) mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359(1):190–200PubMedGoogle Scholar
  15. Ciancanelli MJ et al (2009) Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism. J Virol 83(16):7828–7841PubMedPubMedCentralGoogle Scholar
  16. Deffrasnes C et al (2016) Genome-wide siRNA Screening at Biosafety Level 4 Reveals a Crucial Role for Fibrillarin in Henipavirus Infection. PLoS Pathog 12(3):e1005478PubMedPubMedCentralGoogle Scholar
  17. Eaton BT et al (2006) Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol 4(1):23–35PubMedGoogle Scholar
  18. Eaton BT, Mackenzie JS Wang LF (2007) Henipaviruses. FIeld’s Virology: Lippincott Williams & WilkinsGoogle Scholar
  19. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6(4):259–269PubMedGoogle Scholar
  20. Fayyad-Kazan H et al (2014) Downregulation of microRNA-24 and -181 parallels the upregulation of IFN-gamma secreted by activated human CD4 lymphocytes. Hum Immunol 75(7):677–685PubMedGoogle Scholar
  21. Flather D, Semler BL (2015) Picornaviruses and nuclear functions: targeting a cellular compartment distinct from the replication site of a positive-strand RNA virus. Front Microbiol 6:594PubMedPubMedCentralGoogle Scholar
  22. Foo CH et al (2016) Dual microRNA Screens Reveal That the Immune-Responsive miR-181 Promotes Henipavirus Entry and Cell-Cell Fusion. PLoS Pathog 12(10):e1005974PubMedPubMedCentralGoogle Scholar
  23. From the Centers for Disease Control and Prevention (1999) Outbreak of Hendra-like virus–Malaysia and Singapore, 1998-1999. JAMA 281(19):1787–1788Google Scholar
  24. Gainey MD et al (2008) Paramyxovirus-induced shutoff of host and viral protein synthesis: role of the P and V proteins in limiting PKR activation. J Virol 82(2):828–839PubMedGoogle Scholar
  25. Galicia JC et al (2014) MiRNA-181a regulates Toll-like receptor agonist-induced inflammatory response in human fibroblasts. Genes Immun 15(5):333–337PubMedPubMedCentralGoogle Scholar
  26. Ghildyal R et al (2003) The matrix protein of Human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription. Arch Virol 148(7):1419–1429PubMedGoogle Scholar
  27. Guo YE, Steitz JA (2014) Virus meets host microRNA: the destroyer, the booster, the hijacker. Mol Cell BiolGoogle Scholar
  28. Halpin K et al (2000) Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J Gen Virol 81(Pt 8):1927–1932PubMedGoogle Scholar
  29. Hao L et al (2008) Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454(7206):890–893PubMedPubMedCentralGoogle Scholar
  30. Hayman DT et al (2008) Evidence of henipavirus infection in West African fruit bats. PLoS One 3(7):e2739PubMedPubMedCentralGoogle Scholar
  31. He L et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435(7043):828–833PubMedPubMedCentralGoogle Scholar
  32. Hieter P, Boguski M (1997) Functional genomics: it’s all how you read it. Science 278(5338):601–602PubMedGoogle Scholar
  33. Hiscox JA (2003) The interaction of animal cytoplasmic RNA viruses with the nucleus to facilitate replication. Virus Res 95(1–2):13–22PubMedGoogle Scholar
  34. Honda K, Taniguchi T (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6(9):644–658PubMedGoogle Scholar
  35. Hossain MJ et al (2008) Clinical presentation of nipah virus infection in Bangladesh. Clin Infect Dis 46(7):977–984PubMedGoogle Scholar
  36. Hunter MP et al (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3(11):e3694PubMedPubMedCentralGoogle Scholar
  37. Hutchison ER et al (2013) Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes. Glia 61(7):1018–1028PubMedPubMedCentralGoogle Scholar
  38. Janssen HL et al (2013) Treatment of HCV infection by targeting microRNA. N Engl J Med 368(18):1685–1694PubMedGoogle Scholar
  39. Karlas A et al (2010) Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463(7282):818–822PubMedGoogle Scholar
  40. Kleinfelter LM et al (2015) Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion. MBio 6(4)Google Scholar
  41. Konig R et al (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135(1):49–60PubMedPubMedCentralGoogle Scholar
  42. Konig R et al (2010) Human host factors required for influenza virus replication. Nature 463(7282):813–817PubMedPubMedCentralGoogle Scholar
  43. Kouznetsova J et al (2015) Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs. Emerg Microbes Infect 3(12):e84Google Scholar
  44. Lamb R, Parks G (2007) Paramyxoviridae: The Viruses and Their Replication. FIeld’s Virology: Lippincott Williams & WilkinsGoogle Scholar
  45. Lee AS, Burdeinick-Kerr R, Whelan SP (2012) A ribosome-specialized translation initiation pathway is required for cap-dependent translation of vesicular stomatitis virus mRNAs. Proc Natl Acad Sci U S A 110(1):324–329PubMedPubMedCentralGoogle Scholar
  46. Liang Y et al (2007) Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8:166PubMedPubMedCentralGoogle Scholar
  47. Lieu KG et al (2015) The non-pathogenic Henipavirus Cedar paramyxovirus phosphoprotein has a compromised ability to target STAT1 and STAT2. Antiviral Res. 124:69–76PubMedGoogle Scholar
  48. Liljeroos L, Butcher SJ (2012) Matrix proteins as centralized organizers of negative-sense RNA virions. Front Biosci (Landmark Ed). 18:696–715Google Scholar
  49. Liu J et al (2013) Mechanism of T cell regulation by microRNAs. Cancer Biol Med 10(3):131–137PubMedPubMedCentralGoogle Scholar
  50. Liu SY et al (2013a) Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity. 38(1):92–105PubMedGoogle Scholar
  51. Luby SP et al (2009a) Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001–2007. Emerg Infect Dis 15(8):1229–1235PubMedPubMedCentralGoogle Scholar
  52. Luby SP, Gurley ES, Hossain MJ (2009b) Transmission of human infection with Nipah virus. Clin Infect Dis 49(11):1743–1748PubMedPubMedCentralGoogle Scholar
  53. Lund JM et al (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 101(15):5598–5603PubMedPubMedCentralGoogle Scholar
  54. Marcel V et al (2013) p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell. 24(3):318–330PubMedGoogle Scholar
  55. Marsh GA et al (2012) Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog. 8(8):e1002836PubMedPubMedCentralGoogle Scholar
  56. Marsh GA et al (2013) Recombinant Hendra viruses expressing a reporter gene retain pathogenicity in ferrets. Virol J 10:95PubMedPubMedCentralGoogle Scholar
  57. Matsumoto M, Oshiumi H, Seya T (2011) Antiviral responses induced by the TLR3 pathway. Rev Med Virol 21(2):67–77PubMedGoogle Scholar
  58. Melen K et al (2012) Influenza A H3N2 subtype virus NS1 protein targets into the nucleus and binds primarily via its C-terminal NLS2/NoLS to nucleolin and fibrillarin. Virol J 9:167PubMedPubMedCentralGoogle Scholar
  59. Middleton D et al (2014) Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health. Emerg Infect Dis 20(3):372–379PubMedPubMedCentralGoogle Scholar
  60. Mohd Nor MN, Gan CH, Ong BL (2000) Nipah virus infection of pigs in peninsular Malaysia. Rev Sci Tech 19(1):160–165Google Scholar
  61. Monaghan P et al (2014) Detailed morphological characterisation of Hendra virus infection of different cell types using super-resolution and conventional imaging. Virol J 11:200PubMedPubMedCentralGoogle Scholar
  62. Murray K et al (1995) A morbillivirus that caused fatal disease in horses and humans. Science 268(5207):94–97PubMedGoogle Scholar
  63. Neel JC, Lebrun JJ (2013) Activin and TGFbeta regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells. Cell Signal 25(7):1556–1566PubMedGoogle Scholar
  64. Neilson JR et al (2007) Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 21(5):578–589PubMedPubMedCentralGoogle Scholar
  65. Oksayan S et al (2012) Subcellular trafficking in rhabdovirus infection and immune evasion: a novel target for therapeutics. Infect Disord Drug Targets 12(1):38–58PubMedGoogle Scholar
  66. Ota A et al (2004) Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64(9):3087–3095PubMedGoogle Scholar
  67. Pederson, T., The nucleus introduced. Cold Spring Harb Perspect Biol, 2010. 3(5)Google Scholar
  68. Peeples ME (1988) Differential detergent treatment allows immunofluorescent localization of the Newcastle disease virus matrix protein within the nucleus of infected cells. Virology 162(1):255–259PubMedGoogle Scholar
  69. Pentecost M et al (2015) Evidence for ubiquitin-regulated nuclear and subnuclear trafficking among Paramyxovirinae matrix proteins. PLoS Pathog 11(3):e1004739PubMedPubMedCentralGoogle Scholar
  70. Pernet O et al (2014) Evidence for henipavirus spillover into human populations in Africa. Nat Commun 5:5342PubMedPubMedCentralGoogle Scholar
  71. Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5(5):375–386PubMedGoogle Scholar
  72. Ponti D et al (2008) The HIV Tat protein affects processing of ribosomal RNA precursor. BMC Cell Biol 9:32PubMedPubMedCentralGoogle Scholar
  73. Rawlinson SM, Moseley GW (2015) The nucleolar interface of RNA viruses. Cell Microbiol 17(8):1108–1120PubMedGoogle Scholar
  74. Roberts AP, Lewis AP, Jopling CL (2011) The role of microRNAs in viral infection. Prog Mol Biol Transl Sci 102:101–139PubMedGoogle Scholar
  75. Rodriguez JJ, Cruz CD, Horvath CM (2004) Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J Virol 78(10):5358–5367PubMedPubMedCentralGoogle Scholar
  76. Rodriguez JJ, Parisien JP, Horvath CM (2002) Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol 76(22):11476–11483PubMedPubMedCentralGoogle Scholar
  77. Rodriguez JJ, Wang LF, Horvath CM (2003) Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol 77(21):11842–11845PubMedPubMedCentralGoogle Scholar
  78. Rodriguez-Corona U et al (2015) Fibrillarin from Archaea to human. Biol Cell 107(6):159–174PubMedGoogle Scholar
  79. Sato H et al (2007) Measles virus N protein inhibits host translation by binding to eIF3-p40. J Virol 81(21):11569–11576PubMedPubMedCentralGoogle Scholar
  80. Schoggins JW, Rice CM (2011) Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1(6):519–525PubMedPubMedCentralGoogle Scholar
  81. Selbach M et al (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455(7209):58–63PubMedGoogle Scholar
  82. Sessions OM et al (2009) Discovery of insect and human dengue virus host factors. Nature 458(7241):1047–1050PubMedPubMedCentralGoogle Scholar
  83. Seth RB et al (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122(5):669–682PubMedGoogle Scholar
  84. Shapira SD et al (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139(7):1255–1267PubMedPubMedCentralGoogle Scholar
  85. Shaw ML et al (2004) Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol 78(11):5633–5641PubMedPubMedCentralGoogle Scholar
  86. Shaw ML et al (2005) Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol 79(10):6078–6088PubMedPubMedCentralGoogle Scholar
  87. Shi XB (2008) C.G. Tepper, and R.W. deVere White, Cancerous miRNAs and their regulation. Cell Cycle 7(11):1529–1538PubMedGoogle Scholar
  88. Skalsky RL, Cullen BR (2010) Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64:123–141PubMedPubMedCentralGoogle Scholar
  89. Stewart CR et al (2013) Promotion of Hendra virus replication by microRNA 146a. J Virol 87(7):3782–3791PubMedPubMedCentralGoogle Scholar
  90. Sun X, Sit A, Feinberg MW (2014) Role of miR-181 family in regulating vascular inflammation and immunity. Trends Cardiovasc Med 24(3):105–112PubMedGoogle Scholar
  91. Takimoto T, Portner A (2004) Molecular mechanism of paramyxovirus budding. Virus Res 106(2):133–145PubMedGoogle Scholar
  92. tenOever BR (2013) RNA viruses and the host micro RNA machinery. Nat Rev Microbiol 11(3):169–180PubMedGoogle Scholar
  93. Tessarz P et al (2013) Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated modification. Nature 505(7484):564–568PubMedPubMedCentralGoogle Scholar
  94. Thomas SM, Lamb RA, Paterson RG (1988) Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54(6):891–902PubMedGoogle Scholar
  95. Triantafilou K et al (2012) Visualisation of direct interaction of MDA5 and the dsRNA replicative intermediate form of positive strand RNA viruses. J Cell Sci 125(Pt 20):4761–4769PubMedGoogle Scholar
  96. Update: outbreak of Nipah virus–Malaysia and Singapore (1999) MMWR Morb Mortal Wkly Rep 48(16):335-337Google Scholar
  97. Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318(5858):1931–1934PubMedGoogle Scholar
  98. Wang YE et al (2010) Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. PLoS Pathog 6(11):e1001186PubMedPubMedCentralGoogle Scholar
  99. Watkinson RE, Lee B (2016) Nipah virus matrix protein: expert hacker of cellular machines. FEBS Lett 590(15):2494–2511PubMedPubMedCentralGoogle Scholar
  100. Weingarten-Gabbay S et al (2016) Comparative genetics. Systematic discovery of cap-independent translation sequences in human and viral genomes. Science 351(6270)PubMedGoogle Scholar
  101. Wilson JA, Sagan SM (2014) Hepatitis C virus and human miR-122: insights from the bench to the clinic. Curr Opin Virol 7C:11–18Google Scholar
  102. Wu Z et al (2014) Novel Henipa-like virus, Mojiang Paramyxovirus, in rats, China, 2012. Emerg Infect Dis 20(6):1064–1066PubMedPubMedCentralGoogle Scholar
  103. Wynne JW et al (2014) Proteomics informed by transcriptomics reveals Hendra virus sensitizes bat cells to TRAIL-mediated apoptosis. Genome Biol 15(11):532PubMedPubMedCentralGoogle Scholar
  104. Xie W et al (2013) miR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo. Biochem Biophys Res Commun 430(2):647–652PubMedGoogle Scholar
  105. Xu X, Xiong X, Sun Y (2016) The role of ribosomal proteins in the regulation of cell proliferation, tumorigenesis, and genomic integrity. Sci China Life Sci 59(7):656–672PubMedGoogle Scholar
  106. Xue Q et al (2011) Human activated CD4(+) T lymphocytes increase IL-2 expression by downregulating microRNA-181c. Mol Immunol 48(4):592–599PubMedGoogle Scholar
  107. Xue S, Barna M (2012) Specialized ribosomes: a new frontier in gene regulation and organismal biology. Nat Rev Mol Cell Biol 13(6):355–369PubMedPubMedCentralGoogle Scholar
  108. Yob JM et al (2001) Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia. Emerg Infect Dis 7(3):439–441PubMedPubMedCentralGoogle Scholar
  109. Yoneyama M et al (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5(7):730–737PubMedGoogle Scholar
  110. Yoshida T et al (1976) Membrane (M) protein of HVJ (Sendai virus): its role in virus assembly. Virology 71(1):143–161PubMedGoogle Scholar
  111. Young PL et al (1996) Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. Emerg Infect Dis 2(3):239–240PubMedPubMedCentralGoogle Scholar
  112. Yuan X et al (2005) Nucleolar localization of non-structural protein 3b, a protein specifically encoded by the severe acute respiratory syndrome coronavirus. Virus Res 114(1–2):70–79PubMedGoogle Scholar
  113. Zhang XD et al (2006) Robust statistical methods for hit selection in RNA interference high-throughput screening experiments. Pharmacogenomics 7(3):299–309PubMedGoogle Scholar
  114. Zhang Y, Wang Z, Gemeinhart RA (2013) Progress in microRNA delivery. J Control Release 172(3):962–974PubMedPubMedCentralGoogle Scholar
  115. Zhou H et al (2008) Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4(5):495–504Google Scholar
  116. Zietara N et al (2013) Critical role for miR-181a/b-1 in agonist selection of invariant natural killer T cells. Proc Natl Acad Sci U S A 110(18):7407–7412PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Cameron R. Stewart
    • 1
    Email author
  • Celine Deffrasnes
    • 2
  • Chwan Hong Foo
    • 1
  • Andrew G. D. Bean
    • 1
  • Lin-Fa Wang
    • 3
  1. 1.CSIRO Health and BiosecurityAustralian Animal Health LaboratoryGeelongAustralia
  2. 2.Department of MicrobiologyMonash UniversityClaytonAustralia
  3. 3.Programme in Emerging Infectious DiseasesDuke-NUS Medical SchoolSingaporeSingapore

Personalised recommendations